---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-217229"
form_type: "8-K"
ticker: "INAB"
cik: "0001740279"
company_name: "IN8BIO, INC."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:27:33.705161+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# IN8bio CMO Trishna Goswami steps down effective Sept 6, 2024

## Summary
- Dr. Goswami and company mutually agreed to her departure as Chief Medical Officer.
- Separation agreement provides two months' base salary cash severance.
- Agreement includes general release, non-disparagement, confidentiality, and cooperation covenants.
- Full separation agreement to be filed as exhibit to Q3 2024 10-Q.

## SEC filing metadata
- accession: 0001193125-24-217229
- form_type: 8-K
- ticker: INAB
- cik: 0001740279
- company_name: IN8BIO, INC.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740279/000119312524217229/0001193125-24-217229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740279/000119312524217229/d853919d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-217229
- JSON: https://secwatch.observer/filing/0001193125-24-217229.json
- Plain text: https://secwatch.observer/filing/0001193125-24-217229.txt

## Key facts
- Executive change
  Trishna Goswami departed as Chief Medical Officer at IN8BIO, INC..
  - Action: stepped down
  - Role: Chief Medical Officer
  source text: On September 8, 2024, IN8bio, Inc. (the “Company”) and Trishna Goswami, M.D., the Company’s Chief Medical Officer, reached the mutual decision to have Dr. Goswami step down as Chief Medical Officer, effective September 6, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740279/000119312524217229/0001193125-24-217229-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.